Clinical trials
Phase 2 Hereditary Sensory and Autonomic Neuropathies trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2021 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| EMD Serono Research & Development Institute, Inc. | 2 |
| Incyte Corporation | 2 |
| Pfizer | 2 |
| AllRock Bio, Inc. | 1 |
| Benedetto Falsini | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Cancer Institute, Naples | 1 |
| Novartis Pharmaceuticals | 1 |
| Revolution Medicines, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hereditary Sensory and Autonomic Neuropathies | 12 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Breast Neoplasms | 1 |
| Bronchial Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Congenital Abnormalities | 1 |
| Endometrial Neoplasms | 1 |
| Hypertension, Pulmonary | 1 |
| Lung Diseases | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.